Disse bivirkninger blev observeret lidt oftere hos patienter i behandling med InductOs for skinnebensbrud end hos patienter, som ikke blev behandlet med dette produkt.
These were observed slightly more frequently in patients treated with InductOs for shin bone studies than in patients who did not receive the product.